MYC and neoplasm: On the contrary, lncRNAFGF12-AS1 [42] and lncRNAKCNQ1DN [43] are downregulated in breast cancer and renal cell carcinoma, respectively, and were shown to inhibit tumor proliferation, invasion, migration, and glycolysis by reducing the expression of c-Myc.